Method for using ergoline compounds to effect physiological and pathological functions at the 5-HT.sub.7 receptor
US5880134A · kind A · utility
3Cited by
6References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 1997 |
| Grant date | Mar 9, 1999 |
| Priority date | — |
| Expiry date | Oct 7, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/48
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method for altering mammalian central and peripheral physiological and pathological functioning which is mediated by serotonin binding to the 5-HT.sub.7 receptor. Specifically, the invention provides a method for antagonizing serotonin binding to the 5-HT.sub.7 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.